Not 100% Atta: FSSAI Slams ‘Eat Fit Digestive Biscuits’ for Deceptive Health Claims

Date:

Share post:

The Food Safety and Standards Authority of India (FSSAI) has issued an official notice to SAJ Food Products following a consumer complaint regarding misleading labeling on their “Eat Fit Digestive Biscuits.”

The initial complaint pointed out that while the front label prominently advertised “100% Atta,” the product’s actual ingredients list declared only 72.33% atta. Upon investigation, FSSAI flags multiple non-compliances. Beyond the misleading “100% Atta” claim which contains other additives and violates an FSSAI advisory against using “100%” claims the regulator also found the “No Added Sugar” label to be deceptive, as the biscuits contain maltodextrin and glucose syrup solids. Furthermore, FSSAI stated that the product name “Eat Fit Digestive” requires formal scientific justification under the Food Safety and Standards (Advertising & Claims) Regulations, 2018.

SAJ Food Products has been strictly directed to furnish a detailed explanation within 7 days. Failure to provide a satisfactory response within this timeframe will prompt the regulator to initiate formal legal and regulatory action under the provisions of the FSS Act, 2006.

Written by: Pragna Biswas

Graphics by: Pramit Hazra

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Bhawanipur Global Campus Announces iNATCONPH 2026: A Global Platform for Pharmacy & Allied Health Research

Kolkata: Bhawanipur Global Campus has announced the 16th International Conference - iNATCONPH 2026, a prestigious international scientific conference...

Emcure Pharma Receives CDSCO Approval to Launch Poviztra®️ for Fatty Liver Disease Treatment

Emcure Pharmaceuticals Ltd  announced that its co-marketed semaglutide brand, Poviztra®, has received regulatory approval from the Central Drugs...

CDSCO Partners with THSTI to Strengthen Vaccine and Healthcare innovation

The Central Drugs Standard Control Organization (CDSCO), India’s national regulatory authority, and the Translational Health Science and Technology...

EMeRG Launches Hospital Intel Suite™️ to transform MedTech Market

EMeRG, a leading healthcare intelligence provider with over a decade of industry expertise,  announced the launch of Hospital...